The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 28, 2020

Filed:

May. 09, 2017
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services (The Government), Bethesda, MD (US);

Inventors:

Dimiter S. Dimitrov, Frederick, MD (US);

Tianlei Ying, Shanghai, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/10 (2006.01); C07K 16/28 (2006.01); C07K 14/735 (2006.01); C07K 16/00 (2006.01); G01N 33/68 (2006.01); G01N 33/573 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); G01N 33/544 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/283 (2013.01); C07K 14/005 (2013.01); C07K 16/00 (2013.01); C07K 16/1045 (2013.01); C07K 16/1063 (2013.01); C12N 7/00 (2013.01); G01N 33/544 (2013.01); G01N 33/573 (2013.01); G01N 33/6863 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/31 (2013.01); C07K 2317/52 (2013.01); C07K 2317/524 (2013.01); C07K 2317/526 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/64 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C07K 2318/20 (2013.01); C07K 2319/30 (2013.01); C07K 2319/74 (2013.01); C12N 2740/16111 (2013.01);
Abstract

Fc domains and CH3 domains are disclosed that bind the neonatal Fc (FcRn) receptor and are at least 99% monomeric. Monomeric Fc domain molecules and CH3 domain molecules are disclosed herein that include a monomeric Fc domain or a monomeric CH3 domain and an effector molecule. In some embodiments, the monomeric Fc or monomeric CH3 domain include amino acid substitutions and/or CDR insertions in the beta strands such that they specifically bind an antigen. Methods for using these monomeric Fc domains, monomeric CH3 domains, monomeric Fc domain molecules and CH3 domain molecules are also provided.


Find Patent Forward Citations

Loading…